- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JK-07-0012315

MSBC Pharmaceuticals Private Limited
About MSBC Pharmaceuticals Private Limited
Data last updated:
MSBC Pharmaceuticals Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24290JK2018PTC010403.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chetan Choudhary and Parul Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 4 Colonel Hiranand Wazarat Road, Jammu, Jammu and Kashmir, India – 180001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.84 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹4,687 (net margin 0.7%) and EBITDA of ₹11,368 (EBITDA margin 1.7%).
MSBC Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-07-0012315).
Company details
Recognitions & Rankings of MSBC Pharmaceuticals
Contact details
MSBC Pharmaceuticals Private Limited's registered office is in Jammu, Jammu And Kashmir.
- Registered AddressHouse No 4 Colonel Hiranand Wazarat Road, Jammu, Jammu and Kashmir, India – 180001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of MSBC Pharmaceuticals Private Limited
FY 2025 filings availableMSBC Pharmaceuticals Private Limited reported revenue of ₹6.84 Lakh (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year. EBITDA fell 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,368 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,687 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MSBC Pharmaceuticals Private Limited, buy the company report.
Board of directors of MSBC Pharmaceuticals Private Limited
MSBC Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetan Choudhary | Director | 16 Apr 2018 | 8 Years 6 Months | Current |
| Parul Agarwal | Director | 17 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
MSBC Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anormed Pharmaceuticals Private Limited | ₹6.86 Lakh (FY 2024) | 520.0% | Mumbai, Maharashtra, India | |||
| Medoholic Pharmaceuticals Private Limited | ₹6.86 Lakh (FY 2024) | 28.0% | Araria, Bihar, India | |||
| Eupid Pharmaceuticals Private Limited | ₹6.86 Lakh (FY 2025) | 16.0% | Dadri, Uttar Pradesh, India | |||
| Anivig Pharmaceuticals Private Limited | ₹6.86 Lakh (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Stormgen Pharmaceuticals Private Limited | ₹6.85 Lakh (FY 2024) | -48.0% | Hyderabad, Telangana, India | |||
| MSBC Pharmaceuticals Private Limitedthis company | ₹6.84 Lakh (FY 2025) | ₹4,687 | 0.7% | -28.0% | Jammu, Jammu And Kashmir, India | |
| Afromax Pharmaceuticals Private Limited | ₹6.84 Lakh (FY 2025) | 2.0% | Patna, Bihar, India | |||
| Shiv Hari Pharmaceuticals Private Limited | ₹6.81 Lakh (FY 2025) | -88.0% | Mysore, Karnataka, India | |||
| Liman Pharmaceuticals Private Limited | ₹6.8 Lakh (FY 2025) | -36.0% | Lucknow, Uttar Pradesh, India | |||
| WDRK Pharmaceuticals Private Limited | ₹6.77 Lakh (FY 2023) | 23.0% | Delhi, India | |||
| Lepus Pharmaceuticals Private Limited | ₹6.77 Lakh (FY 2025) | -6.0% | Aligarh, Uttar Pradesh, India |
To see the full peer comparison of MSBC Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving MSBC Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MSBC Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for MSBC Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
MSBC Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Parul Agarwal was appointed as Director on 17 Dec 2021.
Frequently asked questions
MSBC Pharmaceuticals is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 April 2018 (8+ years old) and is registered under CIN U24290JK2018PTC010403.
MSBC Pharmaceuticals has 2 current directors:
- Chetan Choudhary - Director
- Parul Agarwal - Director
The latest financial statements of MSBC Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of MSBC Pharmaceuticals is U24290JK2018PTC010403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MSBC Pharmaceuticals was incorporated on 16 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of MSBC Pharmaceuticals by revenue are Anormed Pharmaceuticals Private Limited, Medoholic Pharmaceuticals Private Limited, Eupid Pharmaceuticals Private Limited, Anivig Pharmaceuticals Private Limited, Stormgen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Parul Agarwal was appointed as Director on 17 Dec 2021. Reeta Malhotra ceased to be Director on 17 Dec 2021. Mohd Saqib Bhat ceased to be Director on 15 Jul 2020. MSBC Pharmaceuticals has 4 board changes on record in total.
Yes, MSBC Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-07-0012315).
The registered office of MSBC Pharmaceuticals is at House No 4 Colonel Hiranand Wazarat Road, Jammu, Jammu and Kashmir, India – 180001.
MSBC Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
MSBC Pharmaceuticals can be reached at its registered office: House No 4 Colonel Hiranand Wazarat Road, Jammu, Jammu and Kashmir, India – 180001.